Opportunity ID: 264361
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-PS15-1503 |
| Funding Opportunity Title: | Medical Monitoring Project |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 26 |
| Assistance Listings: | 93.944 — Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Sep 08, 2014 |
| Last Updated Date: | Sep 30, 2014 |
| Original Closing Date for Applications: | Jan 08, 2015 Dates:
Letter of Intent (LOI) Deadline: N/A |
| Current Closing Date for Applications: | Jan 08, 2015 Dates:
Letter of Intent (LOI) Deadline: N/A |
| Archive Date: | Feb 07, 2015 |
| Estimated Total Program Funding: | $96,000,000 |
| Award Ceiling: | $1,800,000 |
| Award Floor: | $300,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | A. Eligibility Information 1. Eligible Applicants: Government Organizations: • State or their bona fide agents (includes the District of Columbia) • Local governments or their bona fide agents • Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) 2. Special Eligibility Requirements: N/A 3. Justification for Less than Maximum Competition: The Medical Monitoring Project or MMP is a national public health surveillance program designed to collect clinical and behavioral information on those diagnosed with HIV or AIDS. Competition for MMP funds is limited to the twenty-six (26) established MMP sites originally selected in 2004. These particular sites were selected to represent the HIV epidemic in the United States. Process for the selection and establishment of MMP sites has been published in a scientific journal; a detailed description of the process used for selection is available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462615/pdf/TOAIDJ-6-67.pdf. The established MMP sites have enabled CDC to obtain data that represent the country as a whole starting in 2004. Ascertainment of representative national data is the goal of MMP. Twenty States or territories, including six jurisdictions which are separately funded for other HIV/AIDS program activities within states, were selected to participate in MMP in 2004. These 26 sites have built the capacity to successfully perform MMP and enable CDC to meet surveillance goals by producing national estimates characterizing the US epidemic. The selected sites were: California Department of Health Services; Chicago Department of Public Health; Delaware Department of Health and Social Services; Florida Department of Health; Georgia Department of Public Health; Houston Department of Health and Human Services; Illinois Department of Public Health; Indiana State Department of Health; Los Angeles County Health Department; Maryland Department of Health and Mental Hygiene; Massachusetts Department of Public Health; Michigan Department of Community Health; Mississippi Department of Health; New Jersey Department of Health and Senior Services; New York City Department of Health and Mental Hygiene; New York State Department of Health; North Carolina Department of Health and Human Services; Oregon Department of Human Services; Pennsylvania Department of Health; Philadelphia Department of Public Health; Puerto Rico Health Department; San Francisco Department of Public Health; South Carolina Department of Health and Environmental Control; Texas Department of State Health Services; Virginia Department of Health; and Washington State Department of Health. These are the twenty-six areas eligible to apply and continue to conduct MMP activities. In order to appropriately use MMP data for prevention and to evaluate national HIV-related health care initiatives including portions of the Affordable Care Act, the data collected in MMP must be nationally representative. If competition is not limited to the 26 established sites listed above, MMP would not be adhering to the scientific sampling strategy chosen for its project design. Without this adherence, MMP data would not be nationally representative and would no longer produce reports that represent the HIV epidemic in the United States. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention |
| Description: | MMP is an ongoing, locally and nationally representative surveillance system that collects data on a probability sample of HIV-diagnosed adults in the United States. MMP monitors sociodemographic variables, behavioral and clinical characteristics, supportive service needs, use of healthcare and prevention services, and adherence to clinical care guidelines among HIV-diagnosed adults. The data from MMP and associated projects are used to help inform and guide local and national HIV prevention, care, and treatment efforts. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDC Procurement and Grants Office
(PGO) Technical Information Management Section (TIMS) Phone: 770-488-2700 E-mail: pgotim@cdc.gov Email:pgotim@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| AMENDMENT II MODIFICATION 9.30.2014 | Sep 30, 2014 | |
| AMENDMENT II MODIFICATION 9.30.2014 | Sep 30, 2014 | |
| Sep 30, 2014 |
DISPLAYING: Synopsis 3
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-PS15-1503 |
| Funding Opportunity Title: | Medical Monitoring Project |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 26 |
| Assistance Listings: | 93.944 — Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Sep 08, 2014 |
| Last Updated Date: | Sep 30, 2014 |
| Original Closing Date for Applications: | Jan 08, 2015 Dates:
Letter of Intent (LOI) Deadline: N/A |
| Current Closing Date for Applications: | Jan 08, 2015 Dates:
Letter of Intent (LOI) Deadline: N/A |
| Archive Date: | Feb 07, 2015 |
| Estimated Total Program Funding: | $96,000,000 |
| Award Ceiling: | $1,800,000 |
| Award Floor: | $300,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | A. Eligibility Information 1. Eligible Applicants: Government Organizations: • State or their bona fide agents (includes the District of Columbia) • Local governments or their bona fide agents • Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) 2. Special Eligibility Requirements: N/A 3. Justification for Less than Maximum Competition: The Medical Monitoring Project or MMP is a national public health surveillance program designed to collect clinical and behavioral information on those diagnosed with HIV or AIDS. Competition for MMP funds is limited to the twenty-six (26) established MMP sites originally selected in 2004. These particular sites were selected to represent the HIV epidemic in the United States. Process for the selection and establishment of MMP sites has been published in a scientific journal; a detailed description of the process used for selection is available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462615/pdf/TOAIDJ-6-67.pdf. The established MMP sites have enabled CDC to obtain data that represent the country as a whole starting in 2004. Ascertainment of representative national data is the goal of MMP. Twenty States or territories, including six jurisdictions which are separately funded for other HIV/AIDS program activities within states, were selected to participate in MMP in 2004. These 26 sites have built the capacity to successfully perform MMP and enable CDC to meet surveillance goals by producing national estimates characterizing the US epidemic. The selected sites were: California Department of Health Services; Chicago Department of Public Health; Delaware Department of Health and Social Services; Florida Department of Health; Georgia Department of Public Health; Houston Department of Health and Human Services; Illinois Department of Public Health; Indiana State Department of Health; Los Angeles County Health Department; Maryland Department of Health and Mental Hygiene; Massachusetts Department of Public Health; Michigan Department of Community Health; Mississippi Department of Health; New Jersey Department of Health and Senior Services; New York City Department of Health and Mental Hygiene; New York State Department of Health; North Carolina Department of Health and Human Services; Oregon Department of Human Services; Pennsylvania Department of Health; Philadelphia Department of Public Health; Puerto Rico Health Department; San Francisco Department of Public Health; South Carolina Department of Health and Environmental Control; Texas Department of State Health Services; Virginia Department of Health; and Washington State Department of Health. These are the twenty-six areas eligible to apply and continue to conduct MMP activities. In order to appropriately use MMP data for prevention and to evaluate national HIV-related health care initiatives including portions of the Affordable Care Act, the data collected in MMP must be nationally representative. If competition is not limited to the 26 established sites listed above, MMP would not be adhering to the scientific sampling strategy chosen for its project design. Without this adherence, MMP data would not be nationally representative and would no longer produce reports that represent the HIV epidemic in the United States. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention |
| Description: | MMP is an ongoing, locally and nationally representative surveillance system that collects data on a probability sample of HIV-diagnosed adults in the United States. MMP monitors sociodemographic variables, behavioral and clinical characteristics, supportive service needs, use of healthcare and prevention services, and adherence to clinical care guidelines among HIV-diagnosed adults. The data from MMP and associated projects are used to help inform and guide local and national HIV prevention, care, and treatment efforts. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDC Procurement and Grants Office
(PGO) Technical Information Management Section (TIMS) Phone: 770-488-2700 E-mail: pgotim@cdc.gov Email:pgotim@cdc.gov |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-PS15-1503 |
| Funding Opportunity Title: | Medical Monitoring Project |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 26 |
| Assistance Listings: | 93.944 — Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Sep 30, 2014 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jan 08, 2015 Dates:
Letter of Intent (LOI) Deadline: N/A |
| Archive Date: | Feb 07, 2015 |
| Estimated Total Program Funding: | $96,000,000 |
| Award Ceiling: | $1,800,000 |
| Award Floor: | $300,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | A. Eligibility Information 1. Eligible Applicants: Government Organizations: • State or their bona fide agents (includes the District of Columbia) • Local governments or their bona fide agents • Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) 2. Special Eligibility Requirements: N/A 3. Justification for Less than Maximum Competition: The Medical Monitoring Project or MMP is a national public health surveillance program designed to collect clinical and behavioral information on those diagnosed with HIV or AIDS. Competition for MMP funds is limited to the twenty-six (26) established MMP sites originally selected in 2004. These particular sites were selected to represent the HIV epidemic in the United States. Process for the selection and establishment of MMP sites has been published in a scientific journal; a detailed description of the process used for selection is available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462615/pdf/TOAIDJ-6-67.pdf. The established MMP sites have enabled CDC to obtain data that represent the country as a whole starting in 2004. Ascertainment of representative national data is the goal of MMP. Twenty States or territories, including six jurisdictions which are separately funded for other HIV/AIDS program activities within states, were selected to participate in MMP in 2004. These 26 sites have built the capacity to successfully perform MMP and enable CDC to meet surveillance goals by producing national estimates characterizing the US epidemic. The selected sites were: California Department of Health Services; Chicago Department of Public Health; Delaware Department of Health and Social Services; Florida Department of Health; Georgia Department of Public Health; Houston Department of Health and Human Services; Illinois Department of Public Health; Indiana State Department of Health; Los Angeles County Health Department; Maryland Department of Health and Mental Hygiene; Massachusetts Department of Public Health; Michigan Department of Community Health; Mississippi Department of Health; New Jersey Department of Health and Senior Services; New York City Department of Health and Mental Hygiene; New York State Department of Health; North Carolina Department of Health and Human Services; Oregon Department of Human Services; Pennsylvania Department of Health; Philadelphia Department of Public Health; Puerto Rico Health Department; San Francisco Department of Public Health; South Carolina Department of Health and Environmental Control; Texas Department of State Health Services; Virginia Department of Health; and Washington State Department of Health. These are the twenty-six areas eligible to apply and continue to conduct MMP activities. In order to appropriately use MMP data for prevention and to evaluate national HIV-related health care initiatives including portions of the Affordable Care Act, the data collected in MMP must be nationally representative. If competition is not limited to the 26 established sites listed above, MMP would not be adhering to the scientific sampling strategy chosen for its project design. Without this adherence, MMP data would not be nationally representative and would no longer produce reports that represent the HIV epidemic in the United States. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention |
| Description: | MMP is an ongoing, locally and nationally representative surveillance system that collects data on a probability sample of HIV-diagnosed adults in the United States. MMP monitors sociodemographic variables, behavioral and clinical characteristics, supportive service needs, use of healthcare and prevention services, and adherence to clinical care guidelines among HIV-diagnosed adults. The data from MMP and associated projects are used to help inform and guide local and national HIV prevention, care, and treatment efforts. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDC Procurement and Grants Office
(PGO) Technical Information Management Section (TIMS) Phone: 770-488-2700 E-mail: pgotim@cdc.gov Email:pgotim@cdc.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-PS15-1503 |
| Funding Opportunity Title: | Medical Monitoring Project |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 26 |
| Assistance Listings: | 93.944 — Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 30, 2014 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jan 08, 2015 Dates:
Letter of Intent (LOI) Deadline: N/A |
| Archive Date: | Feb 07, 2015 |
| Estimated Total Program Funding: | $96,000,000 |
| Award Ceiling: | $1,800,000 |
| Award Floor: | $300,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | A. Eligibility Information 1. Eligible Applicants: Government Organizations: • State or their bona fide agents (includes the District of Columbia) • Local governments or their bona fide agents • Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) 2. Special Eligibility Requirements: N/A 3. Justification for Less than Maximum Competition: The Medical Monitoring Project or MMP is a national public health surveillance program designed to collect clinical and behavioral information on those diagnosed with HIV or AIDS. Competition for MMP funds is limited to the twenty-six (26) established MMP sites originally selected in 2004. These particular sites were selected to represent the HIV epidemic in the United States. Process for the selection and establishment of MMP sites has been published in a scientific journal; a detailed description of the process used for selection is available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462615/pdf/TOAIDJ-6-67.pdf. The established MMP sites have enabled CDC to obtain data that represent the country as a whole starting in 2004. Ascertainment of representative national data is the goal of MMP. Twenty States or territories, including six jurisdictions which are separately funded for other HIV/AIDS program activities within states, were selected to participate in MMP in 2004. These 26 sites have built the capacity to successfully perform MMP and enable CDC to meet surveillance goals by producing national estimates characterizing the US epidemic. The selected sites were: California Department of Health Services; Chicago Department of Public Health; Delaware Department of Health and Social Services; Florida Department of Health; Georgia Department of Public Health; Houston Department of Health and Human Services; Illinois Department of Public Health; Indiana State Department of Health; Los Angeles County Health Department; Maryland Department of Health and Mental Hygiene; Massachusetts Department of Public Health; Michigan Department of Community Health; Mississippi Department of Health; New Jersey Department of Health and Senior Services; New York City Department of Health and Mental Hygiene; New York State Department of Health; North Carolina Department of Health and Human Services; Oregon Department of Human Services; Pennsylvania Department of Health; Philadelphia Department of Public Health; Puerto Rico Health Department; San Francisco Department of Public Health; South Carolina Department of Health and Environmental Control; Texas Department of State Health Services; Virginia Department of Health; and Washington State Department of Health. These are the twenty-six areas eligible to apply and continue to conduct MMP activities. In order to appropriately use MMP data for prevention and to evaluate national HIV-related health care initiatives including portions of the Affordable Care Act, the data collected in MMP must be nationally representative. If competition is not limited to the 26 established sites listed above, MMP would not be adhering to the scientific sampling strategy chosen for its project design. Without this adherence, MMP data would not be nationally representative and would no longer produce reports that represent the HIV epidemic in the United States. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention |
| Description: | MMP is an ongoing, locally and nationally representative surveillance system that collects data on a probability sample of HIV-diagnosed adults in the United States. MMP monitors sociodemographic variables, behavioral and clinical characteristics, supportive service needs, use of healthcare and prevention services, and adherence to clinical care guidelines among HIV-diagnosed adults. The data from MMP and associated projects are used to help inform and guide local and national HIV prevention, care, and treatment efforts. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDC Procurement and Grants Office
(PGO) Technical Information Management Section (TIMS) Phone: 770-488-2700 E-mail: pgotim@cdc.gov Email:pgotim@cdc.gov |
Related Documents
Packages
| Agency Contact Information: | CDC Procurement and Grants Office (PGO) Technical Information Management Section (TIMS) Phone: 770-488-2700 E-mail: pgotim@cdc.gov Email: pgotim@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.944 | NCHHSTP-NR | NCHHSTP-NR | PKG00205303 | Sep 08, 2014 | Jan 08, 2015 | View |
Package 1
Mandatory forms
Optional forms
Share This Post, Choose Your Platform!
About the Author: osnqt
